Josip A Borovac

Cardiology — University of Split, Croatia

LeadR Profile

Josip A Borovac University of Split Croatia
705 ScienceLeadR Reputation 705
Network Map

Cardiology

Subspecialties: Public Health - Biostatistics - Urology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026

Source: PubMed

University of Split

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 204

Citations

Citations: 2 174 1st author: 52 Last author: 42 Unique author: 10


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
JAK inhibitors and adverse cardiovascular events: Class effect or molecule-specific risk?
janus kinase inhibitors
Front Pharmacol20260
Lipoprotein(a) After HORIZON: Causal Culprit, Risk Marker, or Unfulfilled Therapeutic Promise?
lipoproteins, therapeutics, lipoprotein(a)
J Cardiovasc Pharmacol Ther20261
Glucagon-like Peptide-1 Receptor Agonists and Dual Incretin Therapies Across HFpEF and Cardiovascular Outcomes Trials in Patients with Obesity.
diabetes mellitus, glucagon-like peptide 1, glucagon-like peptide-1 receptor, heart failure, heart failure, diastolic, obesity, incretins, glucagon, therapeutics, glucagon-like peptides, semaglutide
Medicina (Kaunas)20260
Deconditioning in coronary artery disease: an underrecognized problem with contemporary clinical relevance.
exercise, myocardial ischemia, coronary artery disease, cardiac rehabilitation, acute coronary syndrome, recycling, arteries, signs and symptoms, angina, stable, coronary disease, therapeutics, sedentary behavior
Coron Artery Dis20260
From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium.
antibodies, cardiovascular diseases, cholesterol, hypolipidemic agents, atherosclerosis, proprotein convertase 9, needles
J Cardiovasc Pharmacol Ther20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 2/Phase 3 1

By status:

Completed 2
Recruiting 1
Unknown 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
SCAD a Registry of Spontaneous Coronary Artery Dissection
NCT06601270 — registries, arteries, vascular diseases, coronary vessel anomalies, aortic dissection, dissection, coronary vessels
N/ARecruiting2021

LeadR Networks

Main global connection map